|
Name |
alpha-Curcumene
|
Molecular Formula | C15H22 | |
IUPAC Name* |
1-methyl-4-(6-methylhept-5-en-2-yl)benzene
|
|
SMILES |
CC1=CC=C(C=C1)C(C)CCC=C(C)C
|
|
InChI |
InChI=1S/C15H22/c1-12(2)6-5-7-14(4)15-10-8-13(3)9-11-15/h6,8-11,14H,5,7H2,1-4H3
|
|
InChIKey |
VMYXUZSZMNBRCN-UHFFFAOYSA-N
|
|
Synonyms |
alpha-Curcumene; Curcumene; Ar-Curcumene; 1-methyl-4-(6-methylhept-5-en-2-yl)benzene; 644-30-4; 2-Methyl-6-p-tolyl-2-heptene; 1-(1,5-Dimethyl-4-hexenyl)-4-methylbenzene; aryl-curcumene; 2-Heptene, 2-methyl-6-p-tolyl-; aromatic curcumene; .alpha.-Curcumene; Benzene, 1-(1,5-dimethyl-4-hexenyl)-4-methyl-; S24T013WOF; UNII-S24T013WOF; alpha-Cucurmene; Curcumene <AR>; CHEMBL4210821; CHEBI:62757; DTXSID90862351; (+/-)-.ALPHA.-CURCUMENE; FT-0778157; 1-(1,5-Dimethyl-4-hexenyl)-4-methylbenzene #; 1-(1,5-dimethyl-hex-4-enyl)-4-methyl-benzene; Q27132148
|
|
CAS | 644-30-4 | |
PubChem CID | 92139 | |
ChEMBL ID | CHEMBL4210821 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 202.33 | ALogp: | 5.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 15 | QED Weighted: | 0.586 |
Caco-2 Permeability: | -4.375 | MDCK Permeability: | 0.00001290 |
Pgp-inhibitor: | 0.787 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.666 |
30% Bioavailability (F30%): | 0.831 |
Blood-Brain-Barrier Penetration (BBB): | 0.24 | Plasma Protein Binding (PPB): | 98.59% |
Volume Distribution (VD): | 4.736 | Fu: | 3.31% |
CYP1A2-inhibitor: | 0.95 | CYP1A2-substrate: | 0.846 |
CYP2C19-inhibitor: | 0.851 | CYP2C19-substrate: | 0.815 |
CYP2C9-inhibitor: | 0.826 | CYP2C9-substrate: | 0.875 |
CYP2D6-inhibitor: | 0.456 | CYP2D6-substrate: | 0.579 |
CYP3A4-inhibitor: | 0.503 | CYP3A4-substrate: | 0.512 |
Clearance (CL): | 12.748 | Half-life (T1/2): | 0.068 |
hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.515 |
Drug-inuced Liver Injury (DILI): | 0.043 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.034 |
Skin Sensitization: | 0.589 | Carcinogencity: | 0.089 |
Eye Corrosion: | 0.49 | Eye Irritation: | 0.985 |
Respiratory Toxicity: | 0.028 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000804 | 0.615 | D0M1PQ | 0.396 | ||||
ENC000199 | 0.511 | D06YPU | 0.333 | ||||
ENC002218 | 0.464 | D0R1QE | 0.328 | ||||
ENC005262 | 0.381 | D0G2KD | 0.304 | ||||
ENC000846 | 0.371 | D0X0WU | 0.296 | ||||
ENC000233 | 0.370 | D06OIV | 0.286 | ||||
ENC002844 | 0.367 | D01AJY | 0.274 | ||||
ENC000221 | 0.347 | D0BZ7W | 0.274 | ||||
ENC000230 | 0.346 | D06GIP | 0.273 | ||||
ENC000311 | 0.346 | D04VMT | 0.271 |